Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Prepaid Assets (2021 - 2025)

Prime Medicine's Prepaid Assets history spans 5 years, with the latest figure at $674000.0 for Q4 2025.

  • For Q4 2025, Prepaid Assets fell 95.4% year-over-year to $674000.0; the TTM value through Dec 2025 reached $674000.0, down 95.4%, while the annual FY2025 figure was $674000.0, 95.4% down from the prior year.
  • Prepaid Assets reached $674000.0 in Q4 2025 per PRME's latest filing, down from $15.6 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $19.2 million in Q3 2023 to a low of -$11.3 million in Q1 2024.
  • Average Prepaid Assets over 5 years is $5.1 million, with a median of $2.9 million recorded in 2025.
  • Peak YoY movement for Prepaid Assets: skyrocketed 816.26% in 2023, then plummeted 383.78% in 2024.
  • A 5-year view of Prepaid Assets shows it stood at $959000.0 in 2021, then crashed by 74.35% to $246000.0 in 2022, then surged by 816.26% to $2.3 million in 2023, then skyrocketed by 550.71% to $14.7 million in 2024, then tumbled by 95.4% to $674000.0 in 2025.
  • Per Business Quant, the three most recent readings for PRME's Prepaid Assets are $674000.0 (Q4 2025), $15.6 million (Q3 2025), and $16.4 million (Q2 2025).